Safety Shot has announced the Notice of Allowance of for a U.S. patent that covers its newest clinically-backed formula. “This latest patent marks a significant milestone in Safety Shot’s quest to lead a brand-new category that the company has created to solve alcohol related problems,” stated Safety Shot COO and co-owner of the patent, David Sandler. “The patent locks up our IP and further separates us from the pack as the only the group that has been able prove that Safety’s Shot revolutionary formula can dramatically reduce blood alcohol and reduce the build-up toxins associated with alcohol consumption rapidly. This patent helps solidify Safety Shot as the uncontested world leader in making people feel better faster,” continued Sandler, who co-invented the Safety Shot wellness product.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHOT:
- Safety Shot announces notice of allowance for new patent to secure IP
- Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims
- Safety Shot Secures Funding for Wellness Drink Expansion
- Safety Shot reports President Jordan Schur Invests additional $3.4M
- Safety Shot President Jordan Schur Invests an Additional $3.4 Million in the Company Through His Family Fund, Core 4 Capital Corp.